Physician

Bertrand M Anz, M.D.

According to 2025 Medicare claims, Bertrand Anz, M.D. (NPI: 1205996014) practices hematology/oncology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37404-1130. Anz is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Anz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,041 traditional Medicare patients, billed 343,400 HCPCS/CPT codes, and received $6,670,126 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,134 prescription claims across 462 beneficiaries totaling $11,464,514 in drug costs, led by Revlimid (Lenalidomide). DME data shows 168 claims. Open Payments data shows 137 records totaling $1,198,184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,830,486 to $6,670,126. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,728,213 to $11,464,514. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,808 to $4,788.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	858	254,216	$2,830,486
2016	926	267,686	$2,956,695
2017	1,084	299,444	$3,222,805
2018	1,029	270,716	$3,397,444
2019	1,067	348,490	$4,593,952
2020	996	354,769	$4,260,919
2021	1,004	285,440	$4,187,642
2022	1,017	266,032	$4,160,918
2023	971	309,624	$5,238,309
2024	1,041	343,400	$6,670,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	294	1,881	$1,728,213
2016	319	1,754	$2,166,924
2017	343	1,958	$3,423,889
2018	345	2,183	$4,538,826
2019	378	2,468	$5,551,739
2020	387	2,282	$6,587,272
2021	376	2,336	$7,503,301
2022	414	2,569	$8,058,440
2023	435	2,692	$9,096,352
2024	462	3,134	$11,464,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	202	$9,228
2016	N/R	131	$24,385
2017	N/R	100	$9,722
2018	N/R	83	$9,566
2019	N/R	67	$5,724
2020	N/R	41	$3,368
2021	N/R	33	$2,088
2022	N/R	121	$4,841
2023	N/R	40	$2,480
2024	N/R	168	$337,170

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	332	540	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	292	487	$12
80053	Blood test, comprehensive group of blood chemicals	496	2,081	$10
36415	Insertion of needle into vein for collection of blood sample	522	2,169	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	561	2,989	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	105	2,843	$1,786,761
Jakafi	Ruxolitinib Phosphate	99	2,970	$1,425,517
Brukinsa	Zanubrutinib	73	2,190	$892,751
Promacta	Eltrombopag Olamine	35	1,170	$712,451
Ninlaro	Ixazomib Citrate	40	1,120	$508,064

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J9039	Injection, blinatumomab, 1 microgram	N	N/R	13	$328,648
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	13	$2,493
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$1,501
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	17	$1,357
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,309

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$644	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	114	$1,197,540	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bertrand M. Anz, M.D.?

Tedicare shows public-source Medicare data for Bertrand M. Anz, M.D. (NPI 1205996014), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bertrand M. Anz, M.D. have ACO affiliation data?

Bertrand M. Anz, M.D. is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Bertrand M. Anz, M.D.?

Bertrand M. Anz, M.D. is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Bertrand M. Anz, M.D. have Open Payments data?

Bertrand M. Anz, M.D. has 137 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.